Integrum

Integrum Payables Turnover

The Payables Turnover Ratio of Integrum (INTEG B.ST) as of Nov 5, 2026 is 2.17. In the previous year, Payables Turnover Ratio was 1.73 — a change of 25.81% (higher).

Payables Turnover

2.17

YoY

25.81%

Last updated:

Payables Turnover Ratio of Integrum is 2025 2.17 . Payables Turnover Ratio of Integrum was 2024 1.73 . It decreases by 25.81% higher compared to the previous year.

The Integrum Payables Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payables Turnover
Date
Payables Turnover
Jan 1, 2018
3.25 SEK
Jan 1, 2019
1.06 SEK
Jan 1, 2020
2.07 SEK
Jan 1, 2021
1.85 SEK
Jan 1, 2022
0.85 SEK
Jan 1, 2023
2.06 SEK
Jan 1, 2024
1.73 SEK
Jan 1, 2025
2.17 SEK
The Integrum Payables Turnover history
YEARPayables TurnoverYoY
2.17+25.81%
1.73-16.23%
2.06+142.93%
0.85-54.23%
1.85-10.37%
2.07+95.93%
1.06-67.47%
3.25+1,492.79%
0.20-32.51%
0.30—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Integrum Stock analysis

What does Integrum do? Integrum AB generates revenue through the sale of medical devices, primarily the OPRA Implant System, which enables osseointegration for direct skeletal attachment of artificial limbs. The company also offers neural prosthetics technology, allowing bionic prostheses to connect directly to bone, nerves, and muscles, alongside a treatment method for phantom limb pain using machine learning, augmented reality, and virtual reality. Prosthetic components required to link the OPRA Implant System to external prostheses are sold as part of the product suite. Customers include individuals with amputations seeking advanced prosthetic solutions, with the company targeting medical professionals and healthcare providers who recommend and implement these systems. The OPRA Implant System, neural prosthetics, and phantom limb pain treatment are key revenue drivers, with the company focusing on high-end medical devices for specialized applications. Prosthetic components serve as complementary products, supporting the primary systems. The business model relies on direct sales to healthcare institutions and clinics specializing in prosthetics and rehabilitation, where the technology is integrated into patient care pathways. Integrum AB's product portfolio is centered around innovative medical solutions for amputees, with the OPRA Implant System as the flagship offering. The neural prosthetics and phantom limb pain treatment methods differentiate the company in the medical device market, addressing both functional and therapeutic needs. Sales of prosthetic components further enhance revenue streams by supporting the full integration of the implant system with external prosthetic devices. Integrum is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Integrum stock

Payables Turnover Ratio of Integrum is 2.17 in 2025.

Payables Turnover Ratio of Integrum changed from 1.73 to 2.17, representing a 25.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Payables Turnover Ratio Integrum since 2006 – with annual values, charts, and detailed analysis.

Payables turnover measures how quickly a company pays its suppliers. Lower turnover may indicate better payment terms or cash flow management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Payables Turnover Ratio's Integrum with sector peers and the industry average to assess whether it is attractive.

To evaluate Payables Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Payables Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Integrum

All Key Metrics — Integrum